ARTICLE SUMMARY:
Stuart Essig speaks about his return to the CEO role at Integra LifeSciences; the AUA's Innovation Nexus is driving investor interest in the urology market; at NASS, the many challenges of selling innovative technologies into the healthcare system; Magenta Medical takes on Abiomed in cardiogenic shock; XVIVO's novel transport device could expand the viability timeframe in heart transplant; and profiles of Signum Surgical and Square Mind.
